Michael Emig
Impact in
-
- Gastric Cancer Management and Outcomes
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
Papers in
- Hematology 11
- Chronic Myeloid Leukemia Treatments 11
-
- Gastric Cancer Management and Outcomes 8
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Kei Muro (6 shared papers)Gyorgy Bodoky (7 shared papers)Eric Van Cutsem (7 shared papers)Atsushi Ohtsu (5 shared papers)Hansjochen Wilke (5 shared papers)Kumari Chandrawansa (4 shared papers)David Raymond Ferry (3 shared papers)Oleg Nikolaevich Lipatov (4 shared papers)
- Journals
- Blood (6 papers)Annals of Oncology (4 papers)Leukemia (4 papers)Clinical Cancer Research (2 papers)Mutation research. Fundamental and molecular mechanisms of mutagenesis (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Michael Emig
33 papers receiving 4.1k citations
Michael Emig's Hit Papers
Peers
Comparison fields: 5 of 90
- Pulmonary and Respiratory Medicine 2.3k
- Hematology 468
- Oncology 768
- Cancer Research 132
- Surgery 339
Countries citing papers authored by Michael Emig
This map shows the geographic impact of Michael Emig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Emig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Emig more than expected).
Fields of papers citing papers by Michael Emig
This network shows the impact of papers produced by Michael Emig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Emig. The network helps show where Michael Emig may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Emig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial Hit paper breakdown → | 2014 | 1968 |
| 2 | Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial Hit paper breakdown → | 2009 | 1123 |
| 3 | 1999 | 230 | |
| 4 | 2000 | 158 | |
| 5 | 2006 | 104 | |
| 6 | 2000 | 83 | |
| 7 | 2015 | 67 | |
| 8 | 2016 | 66 | |
| 9 | 2016 | 65 | |
| 10 | 2005 | 64 | |
| 11 | 2017 | 57 | |
| 12 | 2025 | 37 | |
| 13 | 1996 | 29 | |
| 14 | 1996 | 27 | |
| 15 | 2022 | 20 | |
| 16 | 2000 | 18 | |
| 17 | 2017 | 18 | |
| 18 | 2005 | 16 | |
| 19 | Cetuximab plus platinum-based chemotherapy as 1st-line treatment in patients with non-small cell lung cancer (NSCLC): a meta-analysis of randomized phase II/III trials | 2009 | 16 |
| 20 | 2024 | 13 |
About Michael Emig
Michael Emig is a scholar working on Hematology, Pulmonary and Respiratory Medicine, Immunology, Oncology and Pathology and Forensic Medicine, having authored 35 papers that have together received 4.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (11 papers), Gastric Cancer Management and Outcomes (8 papers), Immune Cell Function and Interaction (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Carcinogens and Genotoxicity Assessment (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.3k citations), Hematology (468 citations), Oncology (768 citations), Cancer Research (132 citations) and Surgery (339 citations). Michael Emig has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Kei Muro, Gyorgy Bodoky, Eric Van Cutsem, Atsushi Ohtsu, Hansjochen Wilke, Kumari Chandrawansa, David Raymond Ferry, Oleg Nikolaevich Lipatov, David Cunningham and Shuichi Hironaka. Their work appears in journals such as Blood, Annals of Oncology, Leukemia, Clinical Cancer Research and Mutation research. Fundamental and molecular mechanisms of mutagenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.